OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
July 02, 2022
Finding specific solutions to overcome uncertainty has led to the evolution of a new clinical trial research environment.
June 30, 2022
Inceptor Bio and the University of Minnesota aim to build a novel iPSC platform to accelerate cell therapy drug development.
June 01, 2022
Precompetitive consortiums seek solutions to industry-wide challenges.
May 26, 2022
AGC Biologics is investing in viral vector suspension technology at its new Longmont, Colo., facility.
May 13, 2022
Through a collaboration, Avantor and Cytovance Biologics will accelerate plasmid optimization and sourcing services for viral vectors and mRNA-based vaccines and therapeutics.
May 11, 2022
Outsourcing partners are ready to fill the market need for greater cell therapies capacities.
May 02, 2022
Complex hurdles complicate the development of emerging therapies.
Plant-based manufacturing technology gains mainstream edge in biopharmaceutical production.
May 01, 2022
Some progress has been made, but improvements are needed when harvesting cells for cell therapies.
April 01, 2022
The booming cell therapy market has created a need for capacity that outsourcing partners are ready to fill.